These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 20083666)

  • 21. A similar local immune and oxidative stress phenotype in vitiligo and halo nevus.
    Yang Y; Li S; Zhu G; Zhang Q; Wang G; Gao T; Li C; Wang L; Jian Z
    J Dermatol Sci; 2017 Jul; 87(1):50-59. PubMed ID: 28385330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cbl-b regulates antigen-induced TCR down-regulation and IFN-gamma production by effector CD8 T cells without affecting functional avidity.
    Shamim M; Nanjappa SG; Singh A; Plisch EH; LeBlanc SE; Walent J; Svaren J; Seroogy C; Suresh M
    J Immunol; 2007 Dec; 179(11):7233-43. PubMed ID: 18025165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Both CD4 and CD8 T cells mediate equally effective in vivo tumor treatment when engineered with a highly avid TCR targeting tyrosinase.
    Frankel TL; Burns WR; Peng PD; Yu Z; Chinnasamy D; Wargo JA; Zheng Z; Restifo NP; Rosenberg SA; Morgan RA
    J Immunol; 2010 Jun; 184(11):5988-98. PubMed ID: 20427771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melanocyte-specific CD8+ T cells are associated with epidermal depigmentation in a novel mouse model of vitiligo.
    You S; Cho YH; Byun JS; Shin EC
    Clin Exp Immunol; 2013 Oct; 174(1):38-44. PubMed ID: 23711243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-gamma (IFN-γ)-mediated retinal ganglion cell death in human tyrosinase T cell receptor transgenic mouse.
    Husain S; Abdul Y; Webster C; Chatterjee S; Kesarwani P; Mehrotra S
    PLoS One; 2014; 9(2):e89392. PubMed ID: 24586745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation and characterization of HLA-A2 transgenic mice expressing the human TCR 1G4 specific for the HLA-A2 restricted NY-ESO-1
    Shenderov E; Kandasamy M; Gileadi U; Chen J; Shepherd D; Gibbs J; Prota G; Silk JD; Yewdell JW; Cerundolo V
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34088742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of functionally active Melan-A(26-35)-specific T cells in the blood of HLA-A2+ vitiligo patients.
    Adams S; Lowes MA; O'Neill DW; Schachterle S; Romero P; Bhardwaj N
    J Invest Dermatol; 2008 Aug; 128(8):1977-80. PubMed ID: 18337837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of the Risk HLA-A Alleles and Autoantigen in Han Chinese Vitiligo Patients and the Association of CD8+T Cell Reactivity with Disease Characteristics.
    Yi X; Cui T; Li S; Yang Y; Chen J; Guo S; Jian Z; Li C; Gao T; Liu L; Li K
    Med Sci Monit; 2018 Sep; 24():6489-6497. PubMed ID: 30219821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partial tyrosinase-specific self tolerance by HLA-A*0201-restricted cytotoxic T lymphocytes in mice and man.
    Lotz C; Ferreira EA; Drexler I; Mutallib SA; Huber C; Sutter G; Theobald M
    Int J Cancer; 2004 Feb; 108(4):571-9. PubMed ID: 14696122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tyrosinase as an autoantigen in patients with vitiligo.
    Baharav E; Merimski O; Shoenfeld Y; Zigelman R; Gilbrud B; Yecheskel G; Youinou P; Fishman P
    Clin Exp Immunol; 1996 Jul; 105(1):84-8. PubMed ID: 8697641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An exhaustion-like phenotype constrains the activity of CD4+ T cells specific for a self and melanoma antigen.
    Rausch MP; Hastings KT
    PLoS One; 2015; 10(4):e0123332. PubMed ID: 25875653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD4 T cell-dependent autoimmunity against a melanocyte neoantigen induces spontaneous vitiligo and depends upon Fas-Fas ligand interactions.
    Lambe T; Leung JC; Bouriez-Jones T; Silver K; Makinen K; Crockford TL; Ferry H; Forrester JV; Cornall RJ
    J Immunol; 2006 Sep; 177(5):3055-62. PubMed ID: 16920942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD8 T cell responses to myelin oligodendrocyte glycoprotein-derived peptides in humanized HLA-A*0201-transgenic mice.
    Mars LT; Bauer J; Gross DA; Bucciarelli F; Firat H; Hudrisier D; Lemonnier F; Kosmatopoulos K; Liblau RS
    J Immunol; 2007 Oct; 179(8):5090-8. PubMed ID: 17911594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Profiles of pulp infiltrating lymphocytes at various times throughout feather regeneration in Smyth line chickens with vitiligo.
    Shresta S; Smyth JR; Erf GF
    Autoimmunity; 1997; 25(4):193-201. PubMed ID: 9344327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
    Zierden M; Kühnen E; Odenthal M; Dienes HP
    Gastroenterology; 2010 Sep; 139(3):975-86, 986.e1-3. PubMed ID: 20639127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral CD8+ T cell tolerance against melanocytic self-antigens in the skin is regulated in two steps by CD4+ T cells and local inflammation: implications for the pathophysiology of vitiligo.
    Steitz J; Brück J; Lenz J; Büchs S; Tüting T
    J Invest Dermatol; 2005 Jan; 124(1):144-50. PubMed ID: 15654968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Manipulation of avidity to improve effectiveness of adoptively transferred CD8(+) T cells for melanoma immunotherapy in human MHC class I-transgenic mice.
    Bullock TN; Mullins DW; Colella TA; Engelhard VH
    J Immunol; 2001 Nov; 167(10):5824-31. PubMed ID: 11698456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mouse Model for Human Vitiligo.
    Riding RL; Richmond JM; Harris JE
    Curr Protoc Immunol; 2019 Feb; 124(1):e63. PubMed ID: 30253067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitiligo puzzle: the pieces fall in place.
    Westerhof W; d'Ischia M
    Pigment Cell Res; 2007 Oct; 20(5):345-59. PubMed ID: 17850508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reactivity to tyrosinase: expression in cancer (melanoma) and autoimmunity (vitiligo).
    Merimsky O; Shoenfeld Y; Baharav E; Zigelman R; Fishman P
    Hum Antibodies Hybridomas; 1996; 7(4):151-6. PubMed ID: 9140726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.